Among the highlights of WCLC are final overall survival (OS) data from AstraZeneca's FLAURA 2 study of EGFR inhibitor Tagrisso (osimertinib) given in combination with chemotherapy as a first-line ...

The final day of the Paris Olympics has arrived, and it stands to be an exciting morning, highlighted by several women's sporting events as the United States looks to overtake China in the race for ...